Current Trends in Clinical Trials of Prodrugs.
Ontology highlight
ABSTRACT: The development of new drugs is a lengthy and complex process regarding its conception and ideation, passing through in silico studies, synthesis, in vivo studies, clinical trials, approval, and commercialization, with an exceptionally low success rate. The lack of efficacy, safety, and suboptimal pharmacokinetic parameters are commonly identified as significant challenges in the discovery of new drugs. To help address these challenges, various approaches have been explored in medicinal chemistry, including the use of prodrug strategies. As a well-established approach, prodrug design remains the best option for improving physicochemical properties, reducing toxicity, and increasing selectivity, all while minimizing costs and saving on biological studies. This review article aims to analyze
SUBMITTER: Boreski D
PROVIDER: S-EPMC11859331 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA